- Condition: Major Depressive Disorder
Intervention: Drug: Ketamine
Sponsors: Massachusetts General Hospital; Massachusetts General Hospital
Recruiting - verified April 2012 - Conditions: Depression; Alcohol Dependence
Intervention: Drug: Ketalar (ketamine)
Sponsors: Yale University; Yale University; VA Connecticut Healthcare System
Recruiting - verified April 2012 - Condition: Suicidal Ideation
Interventions: Drug: Ketamine; Drug: Midazolam
Sponsors: Mount Sinai School of Medicine; James Murrough
Recruiting - verified January 2012 - Conditions: Schizophrenia; Schizoaffective Disorder
Interventions: Drug: D-serine; Drug: placebo; Behavioral: Sensory Based remediation paradigm
Sponsors: Nathan Kline Institute for Psychiatric Research; Nathan Kline Institute for Psychiatric Research; Columbia University
Not yet recruiting - verified July 2011 - Condition: Contraception
Intervention: Drug: one of 5 products
Sponsors: FHI 360; FHI 360; National Institutes of Health (NIH)
Recruiting - verified April 2012 - Condition: Major Depressive Disorder
Intervention: Drug: ketamine
Sponsors: Massachusetts General Hospital; Massachusetts General Hospital
Recruiting - verified April 2012 - Condition: Obsessive-Compulsive Disorder
Interventions: Drug: Ketamine infusion; Other: Saline
Sponsors: New York State Psychiatric Institute; New York State Psychiatric Institute
Recruiting - verified December 2011 - Condition: Alcoholism
Intervention: Drug: acamprosate
Sponsors: Mayo Clinic; Mayo Clinic; Samuel C. Johnson Foundation
Recruiting - verified November 2011
 |
Aspartic Acid Clinical Trials |
